News Focus
News Focus
icon url

Sloan89RH

09/10/22 10:47 AM

#11880 RE: redspeed #11879

I appreciate your perspective regarding the Todos approach to using influencers. And, their approach may have merit. But, if we step back and ask ourselves the following: what are the demographic groups that stand to gain the most from Tollovid/Tollovir, I think we'd have to primarily focus on the elderly, those who are immune compromised, and those in nursing homes. Many elderly have a poor immune response to vaccines and remain very vulnerable even though fully vaccinated and boosted. Targeting Tollovid to this group needs to be a high priority. This demographic group gets first priority to vaccines. It seems to make sense that this group would also be the main focus of any marketing campaign for Tollovid.
icon url

DreyDreyDrey

09/10/22 11:28 AM

#11886 RE: redspeed #11879

Both my kids had Covid. Both completely asymptomatic. It nearly put me in the emergency room and my wife had what I would call a really uncomfortable week. Including the odd symptom of losing her voice completely for 4 days. So couldn’t really talk for about 7 days. Kind of a nice week for me actually. My wife and I are in our 40’s.

You will never sell to a population that has a less than .01% chance of something bad happening. Maybe you market really starts in people’s 40’s. 50’s and 60’s is your sweet spot. Money and a legitimate fear.